ADAMTS13 and thrombotic thrombocytopenic purpura: Current guidelines for diagnosing and managing acute TTP lean heavily towards clinical acumen and a constellation of readily available laboratory markers, pending confirmation of an ADAMTS13 activity of <10 IU/dL.